Mittal Niti, Mittal Rakesh, Goel Nidhi, Parmar Aparna, Bahl Arti, Kaur Suneet, Gudibanda Kavita R, Dudhraj Vibhor, Singh Sujeet K
Department of Pharmacology and Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, India.
Department of Microbiology, Pt. B. D. Sharma Postgraduate Institute of Medical Sciences, Rohtak, India.
Microb Drug Resist. 2023 Jan;29(1):1-9. doi: 10.1089/mdr.2022.0170.
Data on Point Prevalence Surveys (PPSs) in India are limited yet. We report findings of a PPS conducted in a core "National Antimicrobial Consumption Network site" under National Centre for Disease Control - WHO project "Point prevalence survey of antimicrobial consumption at healthcare facilities." A cross-sectional survey was conducted as per the "WHO methodology for PPS on antibiotic use in hospitals" in a tertiary care hospital in India in December 2021. Data were collected using predesigned and pretested questionnaire in separate hospital, ward, and patient forms. Eight hundred two inpatients (excluding ICUs) were covered out of whom 299 (37.3%) were on antibiotics with 11.7% receiving 3 or more antibiotics. Surgical prophylaxis (SP) (42.5%) and community acquired infections (32.8%) were the most common indications for antibiotic use. Of the patients, 92.5% received SP for more than 24 hrs. Most commonly prescribed antibiotics were penicillins with beta-lactamase inhibitors (22.3%). Of the total antibiotic prescriptions, 81.5% were from WHO essential medicines list and 12% from "not recommended" WHO AWaRe classification. Of the antibiotic prescriptions, 84.6% were parenteral. Few prescriptions complied with standard treatment guidelines (1.9%), documented indication for antibiotic use (11.6%), and stop/review date (4.4%) in notes. Double anaerobic cover accounted for 6.8% of the total prescriptions. Some identified areas for improvement were: formulation of hospital antibiotic guidelines, promoting culture of sending cultures, improvement in surgical antibiotic prophylaxis, decreasing use of antibiotic combinations and double anaerobic cover, fostering IV to oral switch of antibiotics, and ensuring effective communication among health care workers by documenting adequate information in medical notes.
印度的点患病率调查(PPS)数据目前仍然有限。我们报告了在疾病控制国家中心-世界卫生组织项目“医疗机构抗菌药物消费点患病率调查”下的一个核心“国家抗菌药物消费网络站点”进行的PPS调查结果。2021年12月,按照“世界卫生组织医院抗生素使用PPS方法”在印度一家三级护理医院进行了横断面调查。使用预先设计和预测试的问卷,以单独的医院、病房和患者表格收集数据。共纳入802名住院患者(不包括重症监护病房),其中299名(37.3%)正在使用抗生素,11.7%的患者接受了3种或更多种抗生素治疗。外科预防(SP)(42.5%)和社区获得性感染(32.8%)是最常见的抗生素使用指征。92.5%的患者接受SP治疗超过24小时。最常开具的抗生素是含β-内酰胺酶抑制剂的青霉素类(22.3%)。在所有抗生素处方中,81.5%来自世界卫生组织基本药物清单,12%来自世界卫生组织AWaRe分类中“不推荐”的药物。84.6%的抗生素处方为胃肠外给药。很少有处方符合标准治疗指南(1.9%)、记录抗生素使用指征(11.6%)和停药/复查日期(4.4%)。双重厌氧菌覆盖占总处方的6.8%。一些确定的改进领域包括:制定医院抗生素指南、促进送检培养物的风气、改善外科抗生素预防、减少抗生素联合使用和双重厌氧菌覆盖、促进抗生素从静脉给药向口服给药的转换,以及通过在病历中记录充分信息确保医护人员之间的有效沟通。